{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:09:52Z","timestamp":1792757392784,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000300","name":"National Osteoporosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00198-022-06453-4","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T01:02:32Z","timestamp":1654909352000},"page":"2245-2257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-2986","authenticated-orcid":false,"given":"Z.","family":"Paskins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Babatunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sturrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. S.","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Maidment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Effectiveness Working Group of the Royal Osteoporosis Society Osteoporosis, Bone Research Academy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Paskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassim","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"McKinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Compston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nic","family":"Vine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"6453_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00198-012-2240-2","volume":"24","author":"F Borgstrom","year":"2013","unstructured":"Borgstrom F, Lekander I, Ivergard M et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)\u2013quality of life during the first 4 months after fracture. Osteoporos Int 24:811\u2013823","journal-title":"Osteoporos Int"},{"key":"6453_CR2","doi-asserted-by":"publisher","first-page":"12S","DOI":"10.1016\/S0002-9343(97)90022-X","volume":"103","author":"C Cooper","year":"1997","unstructured":"Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103:12S-17S","journal-title":"Am J Med"},{"key":"6453_CR3","volume-title":"Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence","author":"NICE","year":"2009","unstructured":"NICE (2009) Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. National Institute for Health and Care Excellence, London"},{"key":"6453_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00198-003-1431-2","volume":"14","author":"A Papaioannou","year":"2003","unstructured":"Papaioannou A, Ioannidis G, Adachi JD et al (2003) Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporos Int 14:808\u2013813","journal-title":"Osteoporos Int"},{"key":"6453_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00198-006-0294-8","volume":"18","author":"E Seeman","year":"2007","unstructured":"Seeman E, Compston J, Adachi J et al (2007) Non-compliance: the Achilles\u2019 heel of anti-fracture efficacy. Osteoporos Int 18:711\u2013719","journal-title":"Osteoporos Int"},{"issue":"11","key":"6453_CR6","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s00198-019-05104-5","volume":"30","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann M, Cornelissen D, Vrijens B et al (2019) Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF). Osteoporos Int 30(11):2155\u20132165","journal-title":"Osteoporos Int"},{"key":"6453_CR7","volume-title":"Medicines optimisation: helping patients to make the most of medicines. Good practice guide for healthcare professionals in England","author":"Royal Pharmaceutical Society","year":"2013","unstructured":"Royal Pharmaceutical Society (2013) Medicines optimisation: helping patients to make the most of medicines. Good practice guide for healthcare professionals in England. Royal Pharmaceutical Society, London"},{"key":"6453_CR8","doi-asserted-by":"publisher","unstructured":"Ryan R, Santesso N, Lowe D et al (2014) Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev (4):CD007768. https:\/\/doi.org\/10.1002\/14651858.CD007768.pub3. Accessed 10 Nov 2021","DOI":"10.1002\/14651858.CD007768.pub3"},{"issue":"9","key":"6453_CR9","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00198-020-05378-0","volume":"31","author":"D Cornelissen","year":"2020","unstructured":"Cornelissen D, de Kunder S, Si L, European Society for Clinical and Economic Aspect of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) et al (2020) Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int 31(9):1645\u20131669","journal-title":"Osteoporos Int"},{"key":"6453_CR10","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00198-009-0976-0","volume":"20","author":"T Gleeson","year":"2009","unstructured":"Gleeson T, Iversen M, Avorn J et al (2009) Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int 20:2127\u20132134","journal-title":"Osteoporos Int"},{"issue":"3","key":"6453_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/135638902401462448","volume":"8","author":"R Pawson","year":"2002","unstructured":"Pawson R (2002) Evidence-based policy: the promise of realist synthesis\u2019. Evaluation 8(3):340\u2013358","journal-title":"Evaluation"},{"issue":"1","key":"6453_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1748-5908-8-103","volume":"8","author":"J Saul","year":"2013","unstructured":"Saul J, Willis C, Bitz J, Best A (2013) A time-responsive tool for informing policy making: rapid realist review. Implement Sci 8(1):103","journal-title":"Implement Sci"},{"issue":"11","key":"6453_CR13","doi-asserted-by":"publisher","first-page":"e040634","DOI":"10.1136\/bmjopen-2020-040634","volume":"10","author":"Z Paskins","year":"2020","unstructured":"Paskins Z, Crawford-Manning F, Cottrell E et al (2020) Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis. BMJ Open 10(11):e040634","journal-title":"BMJ Open"},{"issue":"1","key":"6453_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11657-018-0470-4","volume":"13","author":"G Raybould","year":"2018","unstructured":"Raybould G, Babatunde O, Evans A et al (2018) Expressed information needs of patients with osteoporosis and\/or fragility fractures: a systematic review. Arch Osteoporos 13(1):55","journal-title":"Arch Osteoporos"},{"key":"6453_CR15","volume-title":"Medication management in older people: the MEMORABLE realist synthesis","author":"I Maidment","year":"2020","unstructured":"Maidment I, Lawson S, Wong G et al (2020) Medication management in older people: the MEMORABLE realist synthesis. NIHR Journals Library, Southampton"},{"key":"6453_CR16","unstructured":"Horne R, Weinman J, Barbr N et al (2005) Concordance, adherence and compliance in medicine taking Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). Available at https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2027234. Accessed 10 Nov 2021"},{"key":"6453_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1027\/1016-9040\/a000353","volume":"24","author":"R Horne","year":"2019","unstructured":"Horne R, Cooper V, Wileman V, Chan A (2019) Supporting adherence to medicines for long-term conditions. Eur Psychol 24:82\u201396","journal-title":"Eur Psychol"},{"issue":"4","key":"6453_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"J Hayden","year":"2013","unstructured":"Hayden J, Van der Windt D, Cartwright J et al (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158(4):280\u2013286","journal-title":"Ann Intern Med"},{"key":"6453_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13012-016-0413-7","volume":"11","author":"J Tsang","year":"2015","unstructured":"Tsang J, Blakeman T, Hegarty J et al (2015) Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review. Implement Sci 11:47","journal-title":"Implement Sci"},{"issue":"1","key":"6453_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11657-017-0340-5","volume":"12","author":"Z Paskins","year":"2017","unstructured":"Paskins Z, Jinks C, Mahmood W et al (2017) Public priorities for osteoporosis and fracture research: results from a general population survey. Arch Osteoporos 12(1):45","journal-title":"Arch Osteoporos"},{"issue":"1","key":"6453_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-020-00766-9","volume":"15","author":"A Hawarden","year":"2020","unstructured":"Hawarden A, Jinks C, Mahmood W et al (2020) Public priorities for osteoporosis and fracture research: results from a focus group study. Arch Osteoporos 15(1):1\u201310","journal-title":"Arch Osteoporos"},{"issue":"5","key":"6453_CR22","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00198-015-3038-9","volume":"26","author":"M Bianchi","year":"2015","unstructured":"Bianchi M, Duca P, Vai S et al (2015) Improving adherence to and persistence with oral therapy of osteoporosis. Osteoporos Int 26(5):1629\u20131638","journal-title":"Osteoporos Int"},{"issue":"12","key":"6453_CR23","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s00198-016-3681-9","volume":"27","author":"P Cram","year":"2016","unstructured":"Cram P, Wolinsky F, Lou Y et al (2016) Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial. Osteoporos Int 27(12):3513\u20133524","journal-title":"Osteoporos Int"},{"key":"6453_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40520-016-0538-1","volume":"28","author":"S Gonnelli","year":"2016","unstructured":"Gonnelli S, Caffarelli C, Rossi S et al (2016) How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study. Aging Clin Exp Res 28:459\u2013468","journal-title":"Aging Clin Exp Res"},{"issue":"7","key":"6453_CR25","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00198-021-05823-8","volume":"32","author":"C Liu","year":"2021","unstructured":"Liu C, Feasel A, Kline G, Billington E (2021) Pharmacotherapy decisions among postmenopausal women attending a group medical consultation or a one-on-one specialist consultation at an osteoporosis center: an observational cohort study. Osteoporos Int 32(7):1421\u20131427","journal-title":"Osteoporos Int"},{"issue":"1","key":"6453_CR26","first-page":"67","volume":"49","author":"A Oral","year":"2015","unstructured":"Oral A, Lorenc R (2015) Compliance, persistence, and preference outcomes of postmenopausal osteoporotic women receiving a flexible or fixed regimen of daily risedronate: A multicenter, prospective, parallel group study. Acta Orthop Traumatol Turc 49(1):67\u201374","journal-title":"Acta Orthop Traumatol Turc"},{"issue":"5","key":"6453_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3899\/jrheum.120908","volume":"40","author":"S Roux","year":"2013","unstructured":"Roux S, Beaulieu M, Beaulieu MC et al (2013) Priming primary care physicians to treat osteoporosis after a fragility fracture: an integrated multidisciplinary approach. J Rheumatol 40(5):703\u2013711","journal-title":"J Rheumatol"},{"issue":"1","key":"6453_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11657-021-00889-7","volume":"16","author":"N Sagalla","year":"2021","unstructured":"Sagalla N, Lee R, Lyles K et al (2021) Extent of and reasons for osteoporosis medication non-adherence among veterans and feasibility of a pilot text message reminder intervention. Arch Osteoporos 16(1):21","journal-title":"Arch Osteoporos"},{"key":"6453_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-016-0262-7","volume":"11","author":"P Seuffert","year":"2016","unstructured":"Seuffert P, Sagebien C, McDonnell C et al (2016) Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice. Arch Osteoporos 11:1","journal-title":"Arch Osteoporos"},{"key":"6453_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11657-018-0451-7","volume":"13","author":"S Temachika","year":"2018","unstructured":"Temachika S, Sasaki K, Hayami Y (2018) Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial. Arch Osteoporos 13:67","journal-title":"Arch Osteoporos"},{"key":"6453_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s11657-020-00809-1","volume":"15","author":"M Wilton-Clark","year":"2020","unstructured":"Wilton-Clark M, Feasel L, Kline G, O\u2019Billington E (2020) Autonomy begets adherence: decisions to start and persist with osteoporosis treatment after group medical consultation. Arch Osteoporos 15:138","journal-title":"Arch Osteoporos"},{"key":"6453_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/MD.0000000000009012","volume":"96","author":"D Beaton","year":"2017","unstructured":"Beaton D, Mamdani M, Zheng H et al (2017) Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario Fracture Clinic Screening Program: an interrupted time series analysis. Medicine 96:48","journal-title":"Medicine"},{"issue":"3","key":"6453_CR33","first-page":"e81","volume":"7","author":"V Ducoulombier","year":"2015","unstructured":"Ducoulombier V, Luraschi H, Forzy G et al (2015) Contribution of phone follow-up to improved adherence to oral osteoporosis treatment. Am J Pharm Benefits 7(3):e81\u2013e89","journal-title":"Am J Pharm Benefits"},{"issue":"4","key":"6453_CR34","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00198-013-2610-4","volume":"25","author":"K Ganda","year":"2014","unstructured":"Ganda K, Schaffer A, Pearson Seibel MJ (2014) Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management. Osteoporos Int 25(4):1345\u20131355","journal-title":"Osteoporos Int"},{"key":"6453_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11657-019-0675-1","volume":"15","author":"P Makras","year":"2020","unstructured":"Makras P, Babis G, Chronopoulos E et al (2020) Experience gained from the implementation of the fracture liaison service in Greece. Arch Osteoporos 15:12","journal-title":"Arch Osteoporos"},{"key":"6453_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00198-018-4702-7","volume":"30","author":"F McAlister","year":"2019","unstructured":"McAlister F, Ye C, Beaupre L et al (2019) Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial. Osteoporos Int 30:127\u2013134","journal-title":"Osteoporos Int"},{"issue":"1","key":"6453_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11657-020-00736-1","volume":"15","author":"D Scholten","year":"2020","unstructured":"Scholten D, Bray J, Wang K et al (2020) Implementation of a fracture liaison service and its effects on osteoporosis treatment adherence and secondary fracture at a tertiary care academic health system. Arch Osteoporos 15(1):80","journal-title":"Arch Osteoporos"},{"issue":"1","key":"6453_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-019-0633-y","volume":"14","author":"A Senay","year":"2019","unstructured":"Senay A, Fernandes J, Delisle J et al (2019) Persistence and compliance to osteoporosis therapy in a fracture liaison service: a prospective cohort study. Arch Osteoporos 14(1):1\u201311","journal-title":"Arch Osteoporos"},{"issue":"4","key":"6453_CR39","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00198-017-4340-5","volume":"29","author":"P Van den Berg","year":"2018","unstructured":"Van den Berg P, Van Haard P, Van der Veer E et al (2018) A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates. Osteoporos Int 29(4):813\u2013824","journal-title":"Osteoporos Int"},{"issue":"5","key":"6453_CR40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/jbmr.3395","volume":"33","author":"M Danila","year":"2018","unstructured":"Danila M, Outman R, Rahn E et al (2018) Evaluation of a multimodal, direct-to-patient educational intervention targeting barriers to osteoporosis care: a randomized clinical trial. J Bone Miner Res 33(5):763\u2013772","journal-title":"J Bone Miner Res"},{"issue":"1","key":"6453_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-020-00774-9","volume":"15","author":"M Hitz","year":"2020","unstructured":"Hitz M, Arup S, Holm J et al (2020) Outcome of osteoporosis evaluation, treatment, and follow-up in patients referred to a specialized outpatient clinic compared to patients in care of general practitioners. Arch Osteoporos 15(1):1\u201311","journal-title":"Arch Osteoporos"},{"issue":"5","key":"6453_CR42","doi-asserted-by":"publisher","first-page":"e0128063","DOI":"10.1371\/journal.pone.0128063","volume":"10","author":"A LeBlanc","year":"2015","unstructured":"LeBlanc A, Wang T, Wyatt K et al (2015) Encounter decision aid vs. clinical decision support or usual care to support patient-centered treatment decisions in osteoporosis: the osteoporosis choice randomized trial II. PLoS One 10(5):e0128063","journal-title":"PLoS One"},{"issue":"10","key":"6453_CR43","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/jbmr.3813","volume":"34","author":"W Leslie","year":"2019","unstructured":"Leslie W, Morin S, Martineau P et al (2019) Association of bone density monitoring in routine clinical practice with anti-osteoporosis medication use and incident fractures: a matched cohort study. J Bone Miner Res 34(10):1808\u20131814","journal-title":"J Bone Miner Res"},{"issue":"1","key":"6453_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00198-019-05142-z","volume":"31","author":"C Parsons","year":"2020","unstructured":"Parsons C, Harvey N, Shepstone L et al (2020) Systematic screening using FRAX\u00ae leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial. Osteoporos Int 31(1):67\u201375","journal-title":"Osteoporos Int"},{"issue":"6","key":"6453_CR45","first-page":"1807","volume":"25","author":"A Stuurman-Bieze","year":"2014","unstructured":"Stuurman-Bieze A, Hiddink E, Van Boven J, Vegter S (2014) Proactive pharmaceutical care interventions decrease patients\u2019 nonadherence to osteoporosis medication. Osteoporos Int 25(6):1807\u20131812","journal-title":"Osteoporos Int"},{"issue":"13","key":"6453_CR46","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.7150\/ijms.5359","volume":"10","author":"\u015e T\u00fcz\u00fcn","year":"2013","unstructured":"T\u00fcz\u00fcn \u015e, Aky\u00fcz G, Eskiyurt N et al (2013) Impact of the training on the compliance and persistence of weekly bisphosphonate treatment in postmenopausal osteoporosis: a randomized controlled study. Int J Med Sci 10(13):1880","journal-title":"Int J Med Sci"},{"issue":"9","key":"6453_CR47","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s00198-019-05052-0","volume":"30","author":"M Van Maren","year":"2019","unstructured":"Van Maren M, Wyers C, Driessen J et al (2019) Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program. Osteoporos Int 30(9):1837\u20131844","journal-title":"Osteoporos Int"},{"issue":"6","key":"6453_CR48","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.amjmed.2011.01.013","volume":"124","author":"V Montori","year":"2011","unstructured":"Montori V, Shah N, Pencille L et al (2011) Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J med 124(6):549\u2013556","journal-title":"Am J med"},{"issue":"1","key":"6453_CR49","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1002\/lim2.3","volume":"1","author":"W Baqir","year":"2020","unstructured":"Baqir W, Gray W, Blair A et al (2020) Osteoporosis group consultations are as effective as usual care: results from a non-inferiority randomized trial. Lifestyle Med 1(1):e3","journal-title":"Lifestyle Med"},{"issue":"9","key":"6453_CR50","first-page":"1","volume":"2","author":"C Salter","year":"2014","unstructured":"Salter C, McDaid L, Bhattacharya D et al (2014) Abandoned acid? Understanding adherence to bisphosphonate medications for the prevention of osteoporosis among older women: a qualitative longitudinal study. PLoS ONE 2(9):1","journal-title":"PLoS ONE"},{"issue":"10122","key":"6453_CR51","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","volume":"391","author":"L Shepstone","year":"2018","unstructured":"Shepstone L, Lenaghan E, Cooper C et al (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391(10122):741\u2013747","journal-title":"Lancet"},{"key":"6453_CR52","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00198-015-3116-z","volume":"26","author":"A Cizmic","year":"2015","unstructured":"Cizmic A, Heilmann R, Milchak J et al (2015) Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial. Osteoporos Int 26:2131\u20132136","journal-title":"Osteoporos Int"},{"issue":"3","key":"6453_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.37901\/jcphp16-00032","volume":"64","author":"M Spence","year":"2017","unstructured":"Spence M, Makarem A, Reyes S, Nguyen C (2017) Evaluation of an outpatient pharmacy clinical services program on adherence and fractures among patients with osteoporosis. J Contemp Pharm Pract 64(3):8\u201314","journal-title":"J Contemp Pharm Pract"},{"issue":"2","key":"6453_CR54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.11005\/jbm.2016.23.2.51","volume":"23","author":"JH Nho","year":"2016","unstructured":"Nho JH, Lee YK, Ha YC et al (2016) Can alarming improve compliance with weekly bisphosphonate in patients with osteoporosis? J Bone Metab 23(2):51\u201354","journal-title":"J Bone Metab"},{"key":"6453_CR55","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1210\/jc.2006-1526","volume":"92","author":"P Delmas","year":"2007","unstructured":"Delmas P, Vrijens B, Eastell R et al (2007) Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 92:1296\u20131304","journal-title":"J Clin Endocrinol Metab"},{"key":"6453_CR56","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1210\/jc.2003-030501","volume":"89","author":"J Clowes","year":"2004","unstructured":"Clowes J, Peel N, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89:1117\u20131123","journal-title":"J Clin Endocrinol Metab"},{"key":"6453_CR57","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00198-011-1721-z","volume":"23","author":"S Silverman","year":"2012","unstructured":"Silverman S, Nasser K, Nattrass S et al (2012) Impact of bone turnover markers and\/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial. Osteoporos Int 23:1069\u20131074","journal-title":"Osteoporos Int"},{"issue":"8","key":"6453_CR58","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.clinthera.2015.05.505","volume":"37","author":"K Iglay","year":"2015","unstructured":"Iglay K, Cao X, Mavros P et al (2015) Systematic literature review and meta-analysis of medication adherence with once-weekly versus once-daily therapy. Clin Ther 37(8):1813\u20131821","journal-title":"Clin Ther"},{"issue":"8","key":"6453_CR59","first-page":"786","volume":"20","author":"J Van Boven","year":"2014","unstructured":"Van Boven J, Stuurman-Bieze A, Hiddink E et al (2014) Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Spec Pharm 20(8):786\u2013792","journal-title":"J Manag Care Spec Pharm"},{"key":"6453_CR60","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11657-020-00787-4","volume":"15","author":"N Hui","year":"2020","unstructured":"Hui N, Fraser S, Wong P (2020) Patients discharged from a fracture liaison service still require follow-up and bone health advice. Arch Osteoporos 15:118","journal-title":"Arch Osteoporos"},{"key":"6453_CR61","doi-asserted-by":"crossref","unstructured":"Emmel N, Greenhalgh J, Manzano A et al eds (2018) Doing realist research. Sage,\u00a0London","DOI":"10.4135\/9781526451729"},{"issue":"3","key":"6453_CR62","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1001\/jamainternmed.2015.7667","volume":"176","author":"J Thakkar","year":"2016","unstructured":"Thakkar J, Kurup R, Laba T et al (2016) Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med 176(3):340\u2013349","journal-title":"JAMA Intern Med"},{"issue":"2","key":"6453_CR63","doi-asserted-by":"publisher","first-page":"97","DOI":"10.7326\/0003-4819-155-2-201107190-00005","volume":"155","author":"N Berkman","year":"2011","unstructured":"Berkman N, Sheridan S, Donahue K et al (2011) Low health literacy and health outcomes: an updated systematic review. Ann Intern Med 155(2):97\u2013107","journal-title":"Ann Intern Med"},{"issue":"7","key":"6453_CR64","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/jbmr.3699","volume":"34","author":"S Majumdar","year":"2019","unstructured":"Majumdar S, Lier D, McAlister F et al (2019) Cost-effectiveness of osteoporosis interventions to improve quality of care after upper extremity fracture: results from a randomized trial (C-STOP Trial. J Bone Miner Res 34(7):1220\u20131228","journal-title":"J Bone Miner Res"},{"key":"6453_CR65","volume-title":"Shared Decision Making","author":"NICE","year":"2021","unstructured":"NICE (2021) Shared Decision Making. National Institute for Health and Care Excellence, London"},{"key":"6453_CR66","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","volume":"348","author":"T Hoffmann","year":"2014","unstructured":"Hoffmann T, Glasziou P, Boutron I et al (2014) Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 348:g1687","journal-title":"BMJ"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06453-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06453-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06453-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T07:04:00Z","timestamp":1665731040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06453-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6453"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06453-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RH reports speaker engagements with honoraria with the following companies: AbbVie, Abbott, Amgen, Astellas, AstraZeneca, Boehringer Ingelheim, Biogen, Gilead Sciences, GlaxoSmithKline, Janssen, Merck Sharp Dohme, Merck, Novartis, Pfizer, Procter & Gamble, Roche, Sanofi, Shire Pharmaceuticals, TEVA, UCB. RH is Founding Director of a UCL-Business company (Spoonful of Sugar Ltd) providing consultancy on treatment engagement and patient support programmes to healthcare policy makers, providers, and pharmaceutical industry. ZP reports unpaid consultancy for UCB Pharma. OB, AS, LST, and IM report no conflicts of interest. Also, Professor Rob Horne is supported by the National Institute for Health and Care Research (NIHR, Applied Research Collaboration (ARC)), North Thames at Bart\u2019s Health NHS Trust and Asthma UK (AUKCAR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health\u00a0and Social Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}